EUVIMEDOpdag EUVIMED
Open access

Celocentesis for Prenatal Diagnosis of Rare Monogenic Diseases: Development, Validation, and Clinical Outcome on 876 Cases

Antonino Giambona, George Makrydimas, Aurelio Maggio, Filippo Cassarà, Giuseppe Marchese, Filippo Leto, Susanna Marotta, Valentina Cigna, Emanuela Orlandi, Maria Elena Mugavero, Kypros H Nicolaides, Margherita Vinciguerra and 1 more

Prenatal Diagnosis · 2026-08 · 46 (9) · 1411-1422

DOI: 10.1002/pd.70184 ↗

At a glance

Journal article in Prenatal Diagnosis, published online on 2026-05-23. Written by Antonino Giambona and 12 co-authors. Institution: Unit of Molecular Diagnostic Rare Hematological Diseases, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy. Major MEDLINE topics: Prenatal Diagnosis, Rare Diseases, Genetic Diseases, Inborn, Paracentesis. 53 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

To report on the development, validation, and clinical outcomes of 876 consecutive cases of prenatal diagnosis of rare monogenic diseases using celocentesis.

Methods

This retrospective single‐center study, conducted between April 2006 and December 2025, evaluated celomic fluid collected at 7–9 weeks of gestation from women at risk of carrying fetuses with monogenic diseases. Fetal DNA was obtained by isolating embryo‐fetal erythroid precursors. All samples were assessed for the presence of parental molecular defects and maternal cell contamination (MCC).

Results

The median gestational age at the time of celocentesis was 8.4 weeks. Successful aspiration of celomic fluid was achieved in 875/876 cases (99.9%). Although MCC was observed in 98.74% of the samples, an initial subset of 19/190 (10%) was found unsuitable for molecular analysis. Subsequently, an optimized molecular workflow was successfully applied to the remaining cohort, achieving a success rate of 98% (671/685 procedures). Results were validated against confirmatory samples from abortive tissue (following VIP), amniotic fluid, or postnatal blood. All cases were correctly classified, demonstrating 100% sensitivity and specificity.

Conclusion

This study supports the clinical application of celocentesis as a reliable early prenatal diagnostic procedure for monogenic diseases. It represents a viable alternative to Chorionic Villus Sampling (CVS) and amniocentesis, enabling invasive prenatal diagnosis at a significantly earlier stage of pregnancy.

Subjects

MeSH terms (MEDLINE)

Prenatal DiagnosisRare DiseasesGenetic Diseases, InbornParacentesisHumansFemalePregnancyRetrospective StudiesAdultAmniotic Fluid

Author keywords

QF‐PCRcoelocentesishemoglobinopathiesmaternal contaminationprenatal diagnosisshort tandem repeats (STR)thalassemia

Authors and institutions

  • Unit of Molecular Diagnostic Rare Hematological Diseases, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy.
  • Department of Obstetrics & Gynecology, University Hospital of Ioannina, Ioannina, Greece.
  • Foundation Franco and Piera Cutino, Palermo, Italy.
  • Unit of Fetal Medicine and Prenatal Diagnosis, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy.
  • Harris Birthright Research Centre for Fetal Medicine, King's College Hospital, London, UK.

Cite

APA

Giambona, A., Makrydimas, G., Maggio, A., Cassarà, F., Marchese, G., Leto, F., Marotta, S., Cigna, V., Orlandi, E., Mugavero, M. E., Nicolaides, K. H., Vinciguerra, M., & Picciotto, F. (2026). Celocentesis for Prenatal Diagnosis of Rare Monogenic Diseases: Development, Validation, and Clinical Outcome on 876 Cases. Prenatal Diagnosis, 46(9), 1411-1422. https://doi.org/10.1002/pd.70184

Vancouver

Giambona A, Makrydimas G, Maggio A, Cassarà F, Marchese G, Leto F, et al. Celocentesis for Prenatal Diagnosis of Rare Monogenic Diseases: Development, Validation, and Clinical Outcome on 876 Cases. Prenatal Diagnosis. 2026;46(9):1411-1422. doi:10.1002/pd.70184

BibTeX
@article{Giambona2026,
  author = {Giambona, Antonino and Makrydimas, George and Maggio, Aurelio and Cassarà, Filippo and Marchese, Giuseppe and Leto, Filippo and Marotta, Susanna and Cigna, Valentina and Orlandi, Emanuela and Mugavero, Maria Elena and Nicolaides, Kypros H and Vinciguerra, Margherita and Picciotto, Francesco},
  title = {Celocentesis for Prenatal Diagnosis of Rare Monogenic Diseases: Development, Validation, and Clinical Outcome on 876 Cases},
  journal = {Prenatal Diagnosis},
  year = {2026},
  volume = {46},
  number = {9},
  pages = {1411--1422},
  doi = {10.1002/pd.70184}
}
Start for free →